Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Benraadt

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
The Netherlands Journal of Medicine|December 1, 1996
Tamoxifen, balancing risks and benefitsL Bergman, J Benraadt, F E van Leeuwen
Nederlands Tijdschrift Voor Geneeskunde|August 4, 2001
[Diagnostics and treatment of distal bile duct or pancreatic carcinoma; guidelines of the Amsterdam and Twente Comprehensive Cancer Centers]D J Gouma, E H Tilleman, J Benraadt, et al.
Nederlands Tijdschrift Voor Geneeskunde|March 8, 1997
[Cancer incidence in the Schiphol area in 1988-1993]O Visser, J H van Wijnen, J Benraadt, et al.
Nederlands Tijdschrift Voor Geneeskunde|August 4, 2001
[Diagnosis and treatment of pancreatic carcinoma in the region of Amsterdam Comprehensive Cancer Care Center in 1997]E H Tilleman, J Benraadt, P M Bossuyt, et al.
Lancet (London, England)|October 19, 2000
Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of Liver and Endometrial cancer Risk following TamoxifenL Bergman, M L Beelen, M P Gallee, et al.
British Journal of Cancer|March 5, 2002
Cyclin A is a prognostic indicator in early stage breast cancer with and without tamoxifen treatmentR Michalides, H van Tinteren, A Balkenende, et al.
European Journal of Cancer (Oxford, England : 1990)|July 1, 1996
Feasibility of escalating daily doses of cisplatin in combination with accelerated radiotherapy in non-small cell lung cancerA L Schuster-Uitterhoeve, P J van de Vaart, C C Schaake-Koning, et al.
The Netherlands Journal of Medicine|January 4, 2001
Comprehensive Cancer Centre Amsterdam Barrett Advisory Committee: first resultsJ B Hulscher, J Haringsma, J Benraadt, et al.
European Journal of Cancer (Oxford, England : 1990)|March 30, 2000
Toxicity of high-dose radiotherapy combined with daily cisplatin in non-small cell lung cancer: results of the EORTC 08912 phase I/II study. European Organization for Research and Treatment of CancerA L Uitterhoeve, J S Belderbos, M G Koolen, et al.
Lancet (London, England)|February 19, 1994
Risk of endometrial cancer after tamoxifen treatment of breast cancerF E van Leeuwen, J Benraadt, J W Coebergh, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
The Netherlands Journal of Medicine|December 1, 1996
Tamoxifen, balancing risks and benefitsL Bergman, J Benraadt, F E van Leeuwen
Nederlands Tijdschrift Voor Geneeskunde|August 4, 2001
[Diagnostics and treatment of distal bile duct or pancreatic carcinoma; guidelines of the Amsterdam and Twente Comprehensive Cancer Centers]D J Gouma, E H Tilleman, J Benraadt, et al.
Nederlands Tijdschrift Voor Geneeskunde|March 8, 1997
[Cancer incidence in the Schiphol area in 1988-1993]O Visser, J H van Wijnen, J Benraadt, et al.
Nederlands Tijdschrift Voor Geneeskunde|August 4, 2001
[Diagnosis and treatment of pancreatic carcinoma in the region of Amsterdam Comprehensive Cancer Care Center in 1997]E H Tilleman, J Benraadt, P M Bossuyt, et al.
Lancet (London, England)|October 19, 2000
Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of Liver and Endometrial cancer Risk following TamoxifenL Bergman, M L Beelen, M P Gallee, et al.
British Journal of Cancer|March 5, 2002
Cyclin A is a prognostic indicator in early stage breast cancer with and without tamoxifen treatmentR Michalides, H van Tinteren, A Balkenende, et al.
European Journal of Cancer (Oxford, England : 1990)|July 1, 1996
Feasibility of escalating daily doses of cisplatin in combination with accelerated radiotherapy in non-small cell lung cancerA L Schuster-Uitterhoeve, P J van de Vaart, C C Schaake-Koning, et al.
The Netherlands Journal of Medicine|January 4, 2001
Comprehensive Cancer Centre Amsterdam Barrett Advisory Committee: first resultsJ B Hulscher, J Haringsma, J Benraadt, et al.
European Journal of Cancer (Oxford, England : 1990)|March 30, 2000
Toxicity of high-dose radiotherapy combined with daily cisplatin in non-small cell lung cancer: results of the EORTC 08912 phase I/II study. European Organization for Research and Treatment of CancerA L Uitterhoeve, J S Belderbos, M G Koolen, et al.
Lancet (London, England)|February 19, 1994
Risk of endometrial cancer after tamoxifen treatment of breast cancerF E van Leeuwen, J Benraadt, J W Coebergh, et al.
Pageof 2